Pethidine is inappropriate for migraine

Australian Prescriber

Volumn 20, Issue 3, 1997, Pages 71-

  Somogyi, Andrew A ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Adverse effects; Clinical trials; Dependence; Headache

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; CHLORPROMAZINE; CODEINE; DEXTROPROPOXYPHENE; DIHYDROERGOTAMINE; DIMENHYDRINATE; ERGOTAMINE; HYDROXYZINE; KETOROLAC; METOCLOPRAMIDE; PARACETAMOL; PETHIDINE; PROCHLORPERAZINE; PROMETHAZINE; SUMATRIPTAN;

ARTICLE; DRUG ABUSE; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERANCE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; NAUSEA; ORAL DRUG ADMINISTRATION; RECTAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

EID: 0030747676     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.1997.061     Document Type: Article

References (5)

1. Goadsby PJ, Olesen J. Diagnosis and management of migraine. Br Med J 1996;312:1279-83.
2. Moskowitz MA. Drug mechanisms in acute migraine. Prog Pain Res Manag 1994;2:755-64.
3. Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache 1993;33:560-2.
4. Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995;35:256-9.
5. Olesen J. Analgesic headache [editorial]. Br Med J 1995;310:479-80.